Biology subjects

Zippo, A.

Publications and source records attributed to Zippo, A..

4 recordsLinked to original sources

bioRxiv2025

Metastatic cell plasticity is maintained by SOX9 function during mitosis in breast cancer

Disseminated tumor cells (DTCs) contribute to metastasis formation by adapting to the hostile environmental conditions encountered at the seeded secondary organs. This phenotypic plasticity is supported by the epigenetic reprogramming of cis-regulatory elements (CREs), representing a hallmark of metastatic cells. DTCs can enter a reversible state of cancer dormancy, resulting from their ability to enter quiescence after mitosis and escape immune surveillance. In this respect, mitosis may represent a window of opportunity to increase DTCs fitness by priming CREs, ensuring the reactivation of a dormancy-related transcriptional program while preserving the epigenetic information. By profiling the chromatin changes occurring during the early steps of mitosis, we found that DTCs experience fluctuations in chromatin accessibility at CREs, which are bookmarked by pro-metastatic TFs. Among these, the pro-dormancy TF SOX9 remained associated with mitotic chromatin, facilitating transcriptional reactivation upon exiting mitosis. By dissecting the consequences of degrading SOX9 before mitosis, we found that its priming of dormancy-related CREs, combined with the recruitment of the Mediator kinase module, is instrumental for metastatic cells to enter quiescence and escape NK-mediated immune surveillance. These findings indicate that cancer dormancy is primed during mitosis by pro-metastatic TFs.

molecular biology↗

bioRxiv2024

Disruption of autism-associated Pcdh9 gene leads to transcriptional alterations, synapses overgrowth and aberrant excitatory transmission in the CA1

Protocadherins are cell adhesion molecules with crucial role in cell-cell contacts, whose mutations or altered expression have been implicated in multiple brain disorders. In particular, growing evidence links genetic alterations in Protocadherin 9 (PCDH9) gene with Autism Spectrum Disorder (ASD) and Major Depression Disorder (MDD). Furthermore, Pcdh9 deletion induces neuronal defects in the mouse somatosensory cortex, accompanied by sensorimotor and memory impairment. However, the synaptic and molecular mechanisms underlying Pcdh9 physiological function and its involvement in brain pathology remain largely unknown. To this aim, we conducted a comprehensive investigation of PCDH9 role in the mouse hippocampus at the ultrastructural, biochemical, transcriptomic, electrophysiological and network level. We show that PCDH9 mainly localizes at glutamatergic synapses and its expression peaks in the first week after birth, a crucial time window for synaptogenesis. Strikingly, Pcdh9 KO neurons exhibit oversized presynaptic terminal and postsynaptic density (PSD) in the CA1. Synapse overgrowth is sustained by the broad up-regulation of synaptic genes and the dysregulation of key drivers of synapse morphogenesis, as revealed by single-nucleus RNAseq. Synaptic and transcriptional defects are accompanied by increased EPSC frequency and disturbances in the hippocampal network activity of Pcdh9 KO mice. In conclusion, our work indicates that Pcdh9 regulates the morphology and function of excitatory synapses in the CA1, thereby affecting glutamatergic transmission in hippocampal circuitries.

neuroscience↗

bioRxiv2021

Micrometer-resolution reconstruction and analysis of whole mouse brain vasculature by synchrotron-based phase-contrast tomographic microscopy

Nervous tissue metabolism is mainly supported by the dense thread of blood vessels which mainly provides fast supplies of oxygen and glucose. Recently, the supplying role of the brain vascular system has been examined in major neurological conditions such as the Alzheimers and Parkinsons diseases. However, to date, fast and reliable methods for the fine level microstructural extraction of whole brain vascular systems are still unavailable. We present a methodological framework suitable for reconstruction of the whole mouse brain cerebral microvasculature by X-ray tomography with the unprecedented pixel size of 0.65 m. Our measurements suggest that the resolving power of the technique is better than in many previous studies, and therefore it allows for a refinement of current measurements of blood vessel properties. Relevant insights emerged from analyses characterizing the regional morphology and topology of blood vessels. Specifically, vascular diameter and density appeared non-homogeneously distributed among the brain regions suggesting preferential sites for high-demanding metabolic requirements. Also, topological features such as the vessel branching points were non-uniformly distributed among the brain districts indicating that specific architectural schemes are required to serve the distinct functional specialization of the nervous tissue. In conclusion, here we propose a combination of experimental and computational method for efficient and fast investigations of the vascular system of entire organs with submicrometric precision.

neuroscience↗

bioRxiv2017

MYC-driven epigenetic reprogramming favors the onset of tumorigensis by inducing a stem cell-like state

Breast cancer consists of highly heterogeneous tumors, whose cell of origin and driver oncogenes resulted difficult to be uniquely defined. Here we report that MYC acts as tumor reprogramming factor in mammary epithelial cells by inducing an alternative epigenetic program, which triggers loss of cell identity and activation of oncogenic pathways. Over-expression of MYC induces transcriptional repression of lineage-specifying transcription factors, causing decommissioning of luminal-specific enhancers. MYC-driven dedifferentiation supports the onset of a stem cell-like state by inducing the activation of de novo enhancers, which drive the transcriptional activation of oncogenic pathways. Furthermore, we demonstrate that the MYC-driven epigenetic reprogramming favors the formation and maintenance of tumor initiating cells endowed with metastatic capacity. This study supports the notion that MYC-driven tumor initiation relies on cell reprogramming, which is mediated by the activation of MYC-dependent oncogenic enhancers, thus establishing a therapeutic rational for treating basal-like breast cancers.

cancer biology↗